Recalling how a failed stock market bet during his IIM Lucknow days shaped his investing philosophy, the NTO founder urged young people to focus
Author: techrossm
S&P 500, Nasdaq, Dow End Week Higher As Weak Jobs Report Cools Rate Hike Bets — NVDA, BA, SPCX, RIVN, APLD In Focus
The U.S. economy added 29,000 jobs last month, with unemployment rising to 4.2%, lower than what economists expected.
Dow, S&P 500 end lower, but Nasdaq books a gain as long-end yields continue to climb
Two of the three major U.S. stock indexes ended Wednesday lower, with only the Nasdaq Composite Index closing out both the session and the
[Market Forecast for Next Week] Monday, Oct 5 depends on US jobs report results. Nikkei 225 falls 647 yen, snapping a 3-day winning streak; the 69,220 yen ‘key level’ is in …
In today’s Tokyo market on Friday, October 2, the Nikkei 225 fell 647 yen, snapping a 3-day winning streak. The closing price is 68,309
[8/28-10/2] Weekly Stock Market Report: Outlook for Next Week
Price pass-through and profit growth trends indicated by the Tankan survey, the AI semiconductor rally reignited by Micron’s strong earnings, and the full-scale start
Stock Market News, Oct. 2, 2026: Stocks Jump as Hiring Softens
Live updates on markets and the top finance, economics and business stories. Plus the latest on bonds, oil prices, the Dow, S&P 500 and
Dow rises 260 points as weak jobs data lifts US stocks
US stocks ended higher on Friday after weaker-than-expected September jobs data reduced expectations for a Federal Reserve rate hike later this month. The Dow
Why Rivian (RIVN) Stock Is Falling Today
Shares of electric vehicle manufacturer Rivian (NASDAQ:RIVN) fell 3.3% in the afternoon session after the company kept its full-year delivery guidance unchanged despite reporting
Victoria Greene: Buy McDonald’s stock over Nike
Victoria Greene, G Squared Private Wealth CIO, joins ‘The Exchange’ to discuss Nike and McDonald’s stock, Meta and Alphabet, and more.
Why Is Myriad Genetics (MYGN) Stock Soaring Today
Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 5% in the afternoon session after Craig-Hallum analyst John Wilkin raised the firm’s price target